January 2023 DMID Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

Note: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year (FY) 2024 Concepts

FY 2024 Small Business Innovation Research (SBIR) Contract Solicitation Topics

Bioinformatics Resource Centers (BRCs) for Infectious Diseases

For the published request for applications, check the May 15, 2023 Guide notice, Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed).

Animal Models for Hepatitis B and C

For the published request for applications, check the March 28, 2023, Guide announcement, Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed).

Collaborative Partnership to Advance Global Health Research

Program Announcement with Special Receipt, Referral, and/or Review Considerations—proposed FY 2024 initiative

Contact:
Stephanie Coomes
stephanie.coomes@nih.gov

Objective: To develop, establish, implement, and maintain a successful collaborative partnership to advance NIAID priorities, support NIH collaboration on global health, and advance health research internationally.

Description: This initiative would support the development, implementation, establishment, and maintenance of a collaborative partnership to advance health research internationally. Specifically, this funding opportunity announcement seeks to:

  • Support and strengthen international basic, applied, and clinical biomedical research activities to better acquire fundamental scientific knowledge and to apply and advance that knowledge to enhance health.
  • Develop, maintain, and enhance research-related education and advanced training to increase research capability to study the causes, improve diagnosis, implement better prevention methodologies, and seek treatments and cures of human diseases.
  • Develop, maintain, and enhance research-related resources to increase research capability worldwide.
  • Disseminate scientific knowledge to facilitate global utilization of research findings and the coordination of evidence-based improvements in health.
  • Assess and evaluate health-related programs focused on health research and public health.

International Research in Infectious Diseases

For the published request for applications, check the April 14, 2023 Guide announcement, International Research in Infectious Diseases (R01, Clinical Trial Not Allowed)

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae, and Picornaviridae

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed).

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed).

Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC)

For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed).

Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics

For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics.

Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)

For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs).

Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector

For the published notice of special interest, check the October 3, 2022 Guide notice, Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector.

Alternatives to Benzathine Penicillin for Treatment of Syphilis

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.

Request for Proposals

Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Development of Bacteriophage for Treatment of Mycobacterial Infections

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.

Request for Proposals

Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.

Request for Proposals

Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)

Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.

Request for Proposals

Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov

Content last reviewed on